Trial record 1 of 1 for:    NCT01609283
Previous Study | Return to List | Next Study

A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis

This study is currently recruiting participants.
Verified February 2014 by Mayo Clinic
Sponsor:
Information provided by (Responsible Party):
Anthony J. Windebank, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01609283
First received: May 18, 2012
Last updated: February 13, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)